美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

恩宗藥業

0.0588

-0.0012-2.00%

成交量：32.55萬

成交額：1.79萬

市值：436.38萬

市盈率：-0.79

高：0.0606

開：0.0600

低：0.0450

收：0.0600

52周最高：0.1299

52周最低：0.0150

股本：7,421.46萬

流通股本：3,011.40萬

量比：3.78

換手率：1.08%

股息：- -

股息率：- -

每股收益(TTM):-0.0746

每股收益(LYR):-0.0067

淨資產收益率：-7.79%

總資產收益率：-1.88%

市淨率：-1.73

市盈率(LYR):-8.78

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

恩宗藥業

交易所：

OTCQB

成立時間：

1981

員工人數：

1

公司地址：

20 Commerce Drive,Suite 135,Cranford,New Jersey,United States

官網：

http://www.enzon.com

郵編：

07016

電話：

傳真：

- -

簡介：

Enzon Pharmaceuticals, Inc.是一家致力於在病患醫療需求極大的創新療法研究和開發的生物技術公司。這家公司收取從其他相關公司採用該公司專有的聚乙二醇化定製連接器技術的許用證書使用費。這家公司的使用費收入，也就是佩樂能、Sylatron、Macugen , OMONTYS, Oncaspar 和Adagen.。主要的使用費收入是由莫克公司銷售的佩樂能。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ENZN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","market":"US","secType":"STK","nameCN":"恩宗藥業","latestPrice":0.0588,"timestamp":1774382400000,"preClose":0.06,"halted":0,"volume":325481,"delay":15,"changeRate":-0.019999999999999997,"floatShares":30114000,"shares":74214600,"eps":-0.074553,"marketStatus":"盤前交易","change":-0.0012,"latestTime":"03-24 16:00:00 EDT 延時","open":0.06,"high":0.0606,"low":0.045,"amount":17911.658454999993,"amplitude":0.26,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.074553,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774445400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.0588,"volumeRatio":3.776293478404058},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","floatShares":30114000,"roa":"-1.88%","roe":"-7.79%","lyrEps":-0.006696,"volumeRatio":3.776293478404058,"shares":74214600,"dividePrice":0,"high":0.0606,"amplitude":0.26,"preClose":0.06,"low":0.045,"week52Low":0.015,"pbRate":"-1.73","week52High":0.1299,"institutionHeld":0,"latestPrice":0.0588,"eps":-0.074553,"divideRate":0,"volume":325481,"delay":15,"ttmEps":-0.074553,"open":0.06,"prevYearClose":0.0004,"prevWeekClose":0.0006,"prevMonthClose":0.0006,"prevQuarterClose":0.0004,"fiveDayClose":0.0007,"twentyDayClose":0.0007,"sixtyDayClose":0.0004},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENZN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-25","symbol":"ENZN","defaultRemindTime":1774445400000,"type":"split","dateTimestamp":1774411200000,"forFactor":100,"toFactor":1,"ratio":100},{"market":"US","date":"2019-09-30","symbol":"ENZN","amount":0.12,"name":"恩宗药业","recordDate":"2019-10-15","payableDate":"2019-10-01","currency":"USD","type":"dividend","dateTimestamp":1569816000000},{"market":"US","date":"2019-02-20","symbol":"ENZN","amount":0.06,"name":"恩宗药业","recordDate":"2019-03-21","payableDate":"2019-02-21","currency":"USD","type":"dividend","dateTimestamp":1550638800000},{"market":"US","date":"2017-09-29","symbol":"ENZN","amount":0.15,"name":"恩宗药业","recordDate":"2017-09-28","payableDate":"2017-08-30","currency":"USD","type":"dividend","dateTimestamp":1506657600000},{"market":"US","date":"2016-12-30","symbol":"ENZN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1483074000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENZN\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-11-28","paymentDate":"2016-12-12","value":0.15,"currency":"USD"},{"executeDate":"2017-09-29","recordDate":"2017-08-30","paymentDate":"2017-09-28","value":0.15,"currency":"USD"},{"executeDate":"2019-02-20","recordDate":"2019-02-21","paymentDate":"2019-03-21","value":0.06,"currency":"USD"},{"executeDate":"2019-09-30","recordDate":"2019-10-01","paymentDate":"2019-10-15","value":0.12,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENZN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":269599,"yearFounded":1981,"employeeNum":1,"address":"20 Commerce Drive,Suite 135,Cranford,New Jersey,United States","zipCode":"07016","officePhone":"732 980 4500"},"stockCompanyDetail":{"websiteUrl":"http://www.enzon.com","stockEarnings":[{"period":"1week","weight":0.0926},{"period":"1month","weight":-0.0788},{"period":"3month","weight":-0.0604},{"period":"6month","weight":0.0213},{"period":"1year","weight":-0.0451},{"period":"ytd","weight":-0.0679}],"description":"Enzon Pharmaceuticals, Inc.是一家致力於在病患醫療需求極大的創新療法研究和開發的生物技術公司。這家公司收取從其他相關公司採用該公司專有的聚乙二醇化定製連接器技術的許用證書使用費。這家公司的使用費收入，也就是佩樂能、Sylatron、Macugen , OMONTYS, Oncaspar 和Adagen.。主要的使用費收入是由莫克公司銷售的佩樂能。","exchange":"OTCQB","name":"恩宗藥業","nameEN":"Enzon Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ENZN\",market:\"US\",,,undefined,":null}}